市場調査レポート

商品コード

1379667

前臨床イメージングの世界市場 - 産業動向と予測（～2030年）

Global Preclinical Imaging Market - Industry Trends and Forecast to 2030

出版日: 2023年09月01日 | 発行: Data Bridge Market Research

| ページ情報: 英文 477 Pages | 納期: お問合せ

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License) - Printable/Downloadable

USD 4,800 754,272円

レポートPDFを1名様のみご使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License) - Printable/Downloadable

USD 7,000 1,099,980円

レポートPDFを同一企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷も可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の前臨床イメージングの市場規模は、2022年の20億7,050万米ドルから、2030年までに32億9,973万4,830米ドルに達し、2023年～2030年の予測期間にCAGRで6.3%の成長が見込まれています。

当レポートでは、世界の前臨床イメージング市場について調査分析し、産業動向と予測、促進要因と抑制要因、企業情勢などの情報を提供しています。

促進要因
- イメージング分野における技術の進歩
- 研究開発への投資と資金提供の増加
- 慢性疾患の発生率の増加
抑制要因
- 製品の承認に対する厳格な規制枠組み
- 前臨床イメージングシステムの高い設置コストと運用コスト
機会
- 前臨床目的でのイメージングシステムの採用の増加
- 非侵襲性の小動物イメージング手法に対する需要の高まり
課題
- 前臨床イメージングシステムを活用できる熟練した専門家の不足
- イメージングデバイスとその他の技術の統合

第7章世界の前臨床イメージング市場：製品別

概要
システム
- 光学イメージングシステム
- 前臨床核イメージングシステム
- マイクロMRIシステム
- マイクロCTシステム
- マイクロ超音波システム
- 前臨床光音響イメージングシステム
- 前臨床磁気粒子イメージング（MPI）システム
- 磁気共鳴分光イメージング（MRSI）
サービス

第8章世界の前臨床イメージング市場：試薬別

概要
前臨床光学イメージング試薬
- 生物発光イメージング試薬
- 蛍光イメージング試薬
前臨床核イメージング試薬
- 前臨床ペットトレーサー
- 前臨床SPECプローブ
前臨床MRI造影剤
- ガドリニウムベースの前臨床MRI造影剤
- マンガンベースの前臨床MRI造影剤
- 鉄ベースの前臨床MRI造影剤
前臨床超音波造影剤
前臨床CT造影剤
- ヨウ素ベースの前臨床CT造影剤
- バリウムベースの前臨床CT造影剤
- 金ナノ粒子
- ガストログラフィンベースの前臨床CT造影剤

第9章世界の前臨床イメージング市場：用途別

概要
研究開発
創薬
生体内分布
がん細胞の検出
バイオマーカー
その他

第10章世界の前臨床イメージング市場：エンドユーザー別

概要
開発業務受託機関
製薬企業、バイオテクノロジー企業
学術・政府研究機関
診断センター
その他

第11章世界の前臨床イメージング市場：地域別

概要
北米
欧州
アジア太平洋
南米
中東・アフリカ

第12章世界の前臨床イメージング市場、企業情勢

企業シェア分析：世界
企業シェア分析：北米
企業シェア分析：欧州
企業シェア分析：アジア太平洋

第13章 SWOT分析

第14章企業プロファイル

PERKINELMER INC.
FUJIFILM VISUALSONICS, INC
BRUKER
HOLOGIC, INC.
ZEISS INTERNATIONAL
ADVANCED MOLECULAR VISION, INC.
AGILENT TECHNOLOGIES, INC.
AI4R
ASPECT IMAGING LTD.
BERTHOLD TECHNOLOGIES GMBH & CO.KG
CUBRESA INC.
HAMAMATSU PHOTONICS K.K.
IVIM TECHNOLOGY CORP.
KUB TECHNOLOGES INC.
LI-COR, INC.
MEDISO LTD.
MILABS B.V.
MR SOLUTIONS
PHOTON ETC
SOFIE
TRIFOIL IMAGING
VIEWORKS CO., LTD.

第15章アンケート

第16章関連レポート

図表

LIST OF TABLES

TABLE 1 GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 95
TABLE 2 GLOBAL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 3 GLOBAL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 96
TABLE 4 GLOBAL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 96
TABLE 5 GLOBAL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 97
TABLE 6 GLOBAL SERVICES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
TABLE 7 GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 102
TABLE 8 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 9 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 103
TABLE 10 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 11 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 104
TABLE 12 GLOBAL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
TABLE 13 GLOBAL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 105
TABLE 14 GLOBAL PRECLINICAL ULTRASOUND CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 105
TABLE 15 GLOBAL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 106
TABLE 16 GLOBAL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 106
TABLE 17 GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 110
TABLE 18 GLOBAL RESEARCH AND DEVELOPMENT IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 110
TABLE 19 GLOBAL DRUG DISCOVERY IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
TABLE 20 GLOBAL BIO-DISTRIBUTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 111
TABLE 21 GLOBAL CANCER CELL DETECTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
TABLE 22 GLOBAL BIO-MARKERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 112
TABLE 23 GLOBAL OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 113
TABLE 24 GLOBAL PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 116
TABLE 25 GLOBAL CONTRACT RESEARCH ORGANIZATION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 116
TABLE 26 GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 117
TABLE 27 GLOBAL ACADEMIC & GOVERNMENT RESEARCH INSTITUTES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 117
TABLE 28 GLOBAL DIAGNOSTICS CENTER IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 118
TABLE 29 GLOBAL OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 118
TABLE 30 GLOBAL PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
TABLE 31 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 123
TABLE 32 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 123
TABLE 33 NORTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 124
TABLE 34 NORTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 124
TABLE 35 NORTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 125
TABLE 36 NORTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 125
TABLE 37 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 125
TABLE 38 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 126
TABLE 39 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 126
TABLE 40 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 126
TABLE 41 NORTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 127
TABLE 42 NORTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 127
TABLE 43 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 127
TABLE 44 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 127
TABLE 45 NORTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 128
TABLE 46 NORTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 128
TABLE 47 NORTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 128
TABLE 48 NORTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 129
TABLE 49 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
TABLE 50 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 51 U.S. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 131
TABLE 52 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 131
TABLE 53 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 132
TABLE 54 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 132
TABLE 55 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 133
TABLE 56 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 133
TABLE 57 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 133
TABLE 58 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 134
TABLE 59 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 134
TABLE 60 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 134
TABLE 61 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 135
TABLE 62 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 135
TABLE 63 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 135
TABLE 64 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 136
TABLE 65 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 136
TABLE 66 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 136
TABLE 67 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 136
TABLE 68 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 137
TABLE 69 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 137
TABLE 70 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 137
TABLE 71 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 137
TABLE 72 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 138
TABLE 73 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 138
TABLE 74 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 138
TABLE 75 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 139
TABLE 76 U.S. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 139
TABLE 77 U.S. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 78 CANADA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 140
TABLE 79 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 140
TABLE 80 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 141
TABLE 81 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 141
TABLE 82 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 142
TABLE 83 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 142
TABLE 84 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 142
TABLE 85 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 143
TABLE 86 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 143
TABLE 87 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 143
TABLE 88 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 144
TABLE 89 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 144
TABLE 90 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 144
TABLE 91 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 145
TABLE 92 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 145
TABLE 93 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 145
TABLE 94 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 145
TABLE 95 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 146
TABLE 96 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 146
TABLE 97 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 146
TABLE 98 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 146
TABLE 99 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 147
TABLE 100 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 147
TABLE 101 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 147
TABLE 102 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 148
TABLE 103 CANADA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 148
TABLE 104 CANADA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 148
TABLE 105 MEXICO PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 149
TABLE 106 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 149
TABLE 107 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 151
TABLE 108 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
TABLE 109 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 151
TABLE 110 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 152
TABLE 111 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 152
TABLE 112 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 152
TABLE 113 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 152
TABLE 114 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 153
TABLE 115 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 153
TABLE 116 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 153
TABLE 117 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 154
TABLE 118 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 154
TABLE 119 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 154
TABLE 120 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 154
TABLE 121 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 155
TABLE 122 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 155
TABLE 123 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 155
TABLE 124 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 155
TABLE 125 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 156
TABLE 126 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 156
TABLE 127 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 156
TABLE 128 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 157
TABLE 129 MEXICO PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 157
TABLE 130 MEXICO PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
TABLE 131 EUROPE PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 158
TABLE 132 EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 159
TABLE 133 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 159
TABLE 134 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 160
TABLE 135 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 160
TABLE 136 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 160
TABLE 137 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 161
TABLE 138 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 161
TABLE 139 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 161
TABLE 140 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 162
TABLE 141 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 162
TABLE 142 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 162
TABLE 143 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 163
TABLE 144 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 163
TABLE 145 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 163
TABLE 146 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 164
TABLE 147 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 164
TABLE 148 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 164
TABLE 149 EUROPE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 165
TABLE 150 EUROPE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 165
TABLE 151 GERMANY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 166
TABLE 152 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 166
TABLE 153 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 167
TABLE 154 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 167
TABLE 155 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 168
TABLE 156 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 168
TABLE 157 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 168
TABLE 158 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 169
TABLE 159 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 169
TABLE 160 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 169
TABLE 161 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 170
TABLE 162 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 170
TABLE 163 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 170
TABLE 164 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 171
TABLE 165 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 171
TABLE 166 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 171
TABLE 167 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 171
TABLE 168 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 172
TABLE 169 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 172
TABLE 170 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 172
TABLE 171 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 172
TABLE 172 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 173
TABLE 173 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 173
TABLE 174 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 173
TABLE 175 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 174
TABLE 176 GERMANY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 174
TABLE 177 GERMANY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 174
TABLE 178 FRANCE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 175
TABLE 179 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 175
TABLE 180 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 176
TABLE 181 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 176
TABLE 182 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 177
TABLE 183 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 177
TABLE 184 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 177
TABLE 185 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 177
TABLE 186 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 178
TABLE 187 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 178
TABLE 188 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 178
TABLE 189 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 179
TABLE 190 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 179
TABLE 191 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 179
TABLE 192 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 179
TABLE 193 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 180
TABLE 194 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 180
TABLE 195 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 180
TABLE 196 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 180
TABLE 197 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 181
TABLE 198 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 181
TABLE 199 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 181
TABLE 200 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 182
TABLE 201 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 182
TABLE 202 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 182
TABLE 203 FRANCE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 183
TABLE 204 FRANCE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 183
TABLE 205 U.K. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 184
TABLE 206 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 184
TABLE 207 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 185
TABLE 208 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 185
TABLE 209 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 186
TABLE 210 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 186
TABLE 211 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 186
TABLE 212 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 186
TABLE 213 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 187
TABLE 214 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 187
TABLE 215 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 187
TABLE 216 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 188
TABLE 217 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 188
TABLE 218 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 188
TABLE 219 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 188
TABLE 220 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 189
TABLE 221 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 189
TABLE 222 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 189
TABLE 223 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 189
TABLE 224 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 190
TABLE 225 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 190
TABLE 226 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 190
TABLE 227 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 191
TABLE 228 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 191
TABLE 229 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 191
TABLE 230 U.K. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 192
TABLE 231 U.K. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 192
TABLE 232 ITALY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 193
TABLE 233 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 193
TABLE 234 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 194
TABLE 235 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 194
TABLE 236 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 195
TABLE 237 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 195
TABLE 238 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 195
TABLE 239 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 196
TABLE 240 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 196
TABLE 241 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 196
TABLE 242 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 197
TABLE 243 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 197
TABLE 244 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 197
TABLE 245 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 198
TABLE 246 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 198
TABLE 247 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 198
TABLE 248 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 198
TABLE 249 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 199
TABLE 250 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 199

TABLE 251 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 199
TABLE 252 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 199
TABLE 253 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 200
TABLE 254 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 200
TABLE 255 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 200
TABLE 256 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 201
TABLE 257 ITALY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 201
TABLE 258 ITALY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 201
TABLE 259 SPAIN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 202
TABLE 260 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 202
TABLE 261 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 203
TABLE 262 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 203
TABLE 263 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 204
TABLE 264 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 204
TABLE 265 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 204
TABLE 266 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 205
TABLE 267 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 205
TABLE 268 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 205
TABLE 269 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 206
TABLE 270 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 206
TABLE 271 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 206
TABLE 272 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 207
TABLE 273 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 207
TABLE 274 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 207
TABLE 275 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 207
TABLE 276 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 208
TABLE 277 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 208
TABLE 278 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 208
TABLE 279 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 208
TABLE 280 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 209
TABLE 281 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 209
TABLE 282 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 209
TABLE 283 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 210
TABLE 284 SPAIN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 210
TABLE 285 SPAIN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 210
TABLE 286 RUSSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 211
TABLE 287 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 211
TABLE 288 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 212
TABLE 289 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 212
TABLE 290 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 213
TABLE 291 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 213
TABLE 292 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 213
TABLE 293 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 213
TABLE 294 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 214
TABLE 295 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 214
TABLE 296 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 214
TABLE 297 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 215
TABLE 298 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 215
TABLE 299 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 215
TABLE 300 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 215
TABLE 301 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 216
TABLE 302 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 216
TABLE 303 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 216
TABLE 304 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 216
TABLE 305 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 217
TABLE 306 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 217
TABLE 307 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 217
TABLE 308 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 218
TABLE 309 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 218
TABLE 310 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 218
TABLE 311 RUSSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 219
TABLE 312 RUSSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 219
TABLE 313 TURKEY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 220
TABLE 314 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 220
TABLE 315 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 221
TABLE 316 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 221
TABLE 317 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 222
TABLE 318 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 222
TABLE 319 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 222
TABLE 320 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 222
TABLE 321 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 223
TABLE 322 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 223
TABLE 323 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 223
TABLE 324 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 224
TABLE 325 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 224
TABLE 326 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 224
TABLE 327 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 225
TABLE 328 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 225
TABLE 329 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 225
TABLE 330 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 225
TABLE 331 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 225
TABLE 332 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 226
TABLE 333 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 226
TABLE 334 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 226
TABLE 335 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 227
TABLE 336 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 227
TABLE 337 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 227
TABLE 338 TURKEY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 228
TABLE 339 TURKEY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 228
TABLE 340 BELGIUM PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 229
TABLE 341 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 229
TABLE 342 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 230
TABLE 343 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 230
TABLE 344 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 231
TABLE 345 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 231
TABLE 346 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 231
TABLE 347 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 231
TABLE 348 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 232
TABLE 349 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 232
TABLE 350 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 232
TABLE 351 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 233
TABLE 352 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 233
TABLE 353 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 233
TABLE 354 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 233
TABLE 355 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 234
TABLE 356 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 234
TABLE 357 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 234
TABLE 358 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 234
TABLE 359 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 235
TABLE 360 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 235
TABLE 361 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 235
TABLE 362 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 236
TABLE 363 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 236
TABLE 364 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 236
TABLE 365 BELGIUM PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 237
TABLE 366 BELGIUM PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 237
TABLE 367 NETHERLANDS PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 238
TABLE 368 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 238
TABLE 369 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 239
TABLE 370 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 239
TABLE 371 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 240
TABLE 372 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 240
TABLE 373 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 240
TABLE 374 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 240
TABLE 375 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 241
TABLE 376 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 241
TABLE 377 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 241
TABLE 378 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 242
TABLE 379 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 242
TABLE 380 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 242
TABLE 381 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 242
TABLE 382 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 243
TABLE 383 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 243
TABLE 384 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 243
TABLE 385 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 243
TABLE 386 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 244
TABLE 387 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 244
TABLE 388 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 244
TABLE 389 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 245
TABLE 390 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 245
TABLE 391 NETHERLANDS PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 246
TABLE 392 NETHERLANDS PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 246
TABLE 393 SWITZERLAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 246
TABLE 394 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 248
TABLE 395 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 248
TABLE 396 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 249
TABLE 397 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 249
TABLE 398 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 249
TABLE 399 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 250
TABLE 400 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 250
TABLE 401 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 250
TABLE 402 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 251
TABLE 403 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 251
TABLE 404 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 251
TABLE 405 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 252
TABLE 406 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 252
TABLE 407 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 252
TABLE 408 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 252
TABLE 409 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 253
TABLE 410 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 253
TABLE 411 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 253
TABLE 412 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 253
TABLE 413 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 254
TABLE 414 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 254
TABLE 415 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 254
TABLE 416 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 255
TABLE 417 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 255
TABLE 418 SWITZERLAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 255
TABLE 419 SWITZERLAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 256
TABLE 420 REST OF EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 256
TABLE 421 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 257
TABLE 422 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 258
TABLE 423 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 258
TABLE 424 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 259
TABLE 425 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 259
TABLE 426 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 260
TABLE 427 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 260
TABLE 428 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 260
TABLE 429 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 261
TABLE 430 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 261
TABLE 431 ASIA-PACIFIC PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 262
TABLE 432 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 262
TABLE 433 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 262
TABLE 434 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 262
TABLE 435 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 263
TABLE 436 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 263
TABLE 437 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 263
TABLE 438 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 264
TABLE 439 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 264
TABLE 440 CHINA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 265
TABLE 441 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 265
TABLE 442 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 266
TABLE 443 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 266
TABLE 444 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 267
TABLE 445 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 267
TABLE 446 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 267
TABLE 447 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 267
TABLE 448 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 268
TABLE 449 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 268
TABLE 450 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 268
TABLE 451 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 269
TABLE 452 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 269
TABLE 453 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 269
TABLE 454 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 269
TABLE 455 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 270
TABLE 456 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 270
TABLE 457 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 270
TABLE 458 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 270
TABLE 459 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 271
TABLE 460 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 271
TABLE 461 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 271
TABLE 462 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 272
TABLE 463 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 272
TABLE 464 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 272
TABLE 465 CHINA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 273
TABLE 466 CHINA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 273
TABLE 467 JAPAN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 274
TABLE 468 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 274
TABLE 469 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 275
TABLE 470 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 275
TABLE 471 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 276
TABLE 472 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 276
TABLE 473 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 276
TABLE 474 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 276
TABLE 475 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 277
TABLE 476 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 277
TABLE 477 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 277
TABLE 478 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 278
TABLE 479 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 278
TABLE 480 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 278
TABLE 481 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 279
TABLE 482 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 279
TABLE 483 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 279
TABLE 484 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 279
TABLE 485 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 279
TABLE 486 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 280
TABLE 487 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 280
TABLE 488 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 280
TABLE 489 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND) 281
TABLE 490 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME) 281
TABLE 491 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP) 281
TABLE 492 JAPAN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 282
TABLE 493 JAPAN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND) 282
TABLE 494 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 283
TABLE 495 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 283
TABLE 496 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 284
TABLE 497 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 284
TABLE 498 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 285
TABLE 499 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME) 285
TABLE 500 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP) 285

LIST OF FIGURES

FIGURE 1 GLOBAL PRECLINICAL IMAGING MARKET: SEGMENTATION 60
FIGURE 2 GLOBAL PRECLINICAL IMAGING MARKET: DATA TRIANGULATION 63
FIGURE 3 GLOBAL PRECLINICAL IMAGING MARKET: DROC ANALYSIS 64
FIGURE 4 GLOBAL PRECLINICAL IMAGING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 65
FIGURE 5 GLOBAL PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS 65
FIGURE 6 GLOBAL PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS 66
FIGURE 7 GLOBAL PRECLINICAL IMAGING MARKET: MARKET END USERS COVERAGE GRID 68
FIGURE 8 GLOBAL PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID 69
FIGURE 9 GLOBAL PRECLINICAL IMAGING MARKET: VENDOR SHARE ANALYSIS 71
FIGURE 10 GLOBAL PRECLINICAL IMAGING MARKET: SEGMENTATION 75
FIGURE 11 RISING PREVALENCE OF CHRONIC DISORDER AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL PRECLINICAL IMAGING MARKET FROM 2023 TO 2030 76
FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PRECLINICAL MARKET IN 2023 AND 2030 76
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PRECLINICAL IMAGING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 77
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL PRECLINICAL IMAGING MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030 78
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PRECLINICAL IMAGING MARKET 86
FIGURE 16 GLOBAL PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022 94
FIGURE 17 GLOBAL PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022 101
FIGURE 18 GLOBAL PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022 109
FIGURE 19 GLOBAL PRECLINICAL IMAGING MARKET: BY END USER, 2022 115
FIGURE 20 GLOBAL PRECLINICAL IMAGING MARKET: BY SNAPSHOT (2022) 121
FIGURE 21 GLOBAL PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 437
FIGURE 22 NORTH AMERICA PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 438
FIGURE 23 EUROPE PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 439
FIGURE 24 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%) 440

Global preclinical imaging market is expected to reach USD 3,299,734.83 thousand by 2030, from USD 2,070,500.00 thousand in 2022 growing at the CAGR of 6.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Global Preclinical Imaging Market, By Product (Systems and Services), Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, and Preclinical CT Contrast Agents), Application (Research and Development, Drug Discovery, Bio-Distribution, Cancer Cell Detection, Bio-Markers, and Others), End User (Contract Research Organization, Pharmaceutical & Biotech Companies, Academic & Government Research Institutes, Diagnostics Center, and Others), Country (U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, Switzerland, Netherlands, Belgium, Turkey, Russia, Rest of Europe, China, Japan, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Israel, Saudi Arabia, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Global Preclinical Imaging Market Dynamics

Driver
Increasing incidence of chronic diseases
Restraint
High installation and operational cost of preclinical imaging systems
Opportunity
Increasing adoption of imaging systems for preclinical purposes

Market Players

Some of the key market players in the global preclinical imaging market are:

PerkinElmer Inc.
FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation)
Bruker
Hologic, Inc.
ZEISS International
Agilent Technologies, Inc.
Hamamatsu Photonics K.K.
SOFIE
Cubresa Inc.
Vieworks Co., Ltd.
LI-COR, Inc.
Aspect Imaging Ltd.
Berthold Technologies GmbH & Co.KG
MILabs B.V.
Trifoil Imaging
Mediso Ltd.
IVIM Technology Inc.
MR Solutions
Advanced Molecular Vision, Inc.
AI4R
Photon etc
KUB TECHNOLOGIES INC.
Global preclinical imaging market is expected to reach USD 3,299,734.83 thousand by 2030, from USD 2,070,500.00 thousand in 2022 growing at the CAGR of 6.3% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Global Preclinical Imaging Market, By Product (Systems and Services), Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, and Preclinical CT Contrast Agents), Application (Research and Development, Drug Discovery, Bio-Distribution, Cancer Cell Detection, Bio-Markers, and Others), End User (Contract Research Organization, Pharmaceutical & Biotech Companies, Academic & Government Research Institutes, Diagnostics Center, and Others), Country (U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, Switzerland, Netherlands, Belgium, Turkey, Russia, Rest of Europe, China, Japan, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, U.A.E., Israel, Saudi Arabia, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Overview of Global Preclinical Imaging Market Dynamics

Driver
Increasing incidence of chronic diseases
Restraint
High installation and operational cost of preclinical imaging systems
Opportunity
Increasing adoption of imaging systems for preclinical purposes

Market Players

Some of the key market players in the global preclinical imaging market are:

PerkinElmer Inc.
FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation)
Bruker
Hologic, Inc.
ZEISS International
Agilent Technologies, Inc.
Hamamatsu Photonics K.K.
SOFIE
Cubresa Inc.
Vieworks Co., Ltd.
LI-COR, Inc.
Aspect Imaging Ltd.
Berthold Technologies GmbH & Co.KG
MILabs B.V.
Trifoil Imaging
Mediso Ltd.
IVIM Technology Inc.
MR Solutions
Advanced Molecular Vision, Inc.
AI4R
Photon etc
KUB TECHNOLOGIES INC.

1 INTRODUCTION 55

1.1 OBJECTIVES OF THE STUDY 55
1.2 MARKET DEFINITION 55
1.3 OVERVIEW OF THE GLOBAL PRECLINICAL IMAGING MARKET 55
1.4 CURRENCY AND PRICING 57
1.5 LIMITATIONS 57
1.6 MARKETS COVERED 57

2 MARKET SEGMENTATION 60

2.1 MARKETS COVERED 60
2.2 GEOGRAPHICAL SCOPE 61
2.3 YEARS CONSIDERED FOR THE STUDY 62
2.4 DBMR TRIPOD DATA VALIDATION MODEL 63
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.6 MULTIVARIATE MODELLING 67
2.7 PRODUCT SEGMENT LIFELINE CURVE 67
2.8 MARKET END USER COVERAGE GRID 68
2.9 DBMR MARKET POSITION GRID 69
2.10 VENDOR SHARE ANALYSIS 71
2.11 SECONDARY SOURCES 72
2.12 ASSUMPTIONS 72

3 EXECUTIVE SUMMARY 73

4 PREMIUM INSIGHTS 76

4.1 PESTEL ANALYSIS 79
4.2 PORTER'S FIVE FORCES 80
4.3 STRATEGIC INITIATIVES 81

5 REGULATORY FRAMEWORK 82

5.1 REGULATORY SCENARIO IN U.S. 82
5.2 REGULATORY SCENARIO IN AUSTRALIA 82
5.3 REGULATORY SCENARIO IN EUROPE 83
5.4 REGULATORY SCENARIO IN SOUTH AFRICA 83
5.5 REGULATORY SCENARIO IN BRAZIL 84

6 MARKET OVERVIEW 85

6.1 DRIVERS 87
- 6.1.1 INCREASING TECHNOLOGY ADVANCEMENT IN THE FIELD OF IMAGING 87
- 6.1.2 INCREASING NUMBER OF INVESTMENTS AND FUNDING IN RESEARCH AND DEVELOPMENT 87
- 6.1.3 INCREASING INCIDENCE OF CHRONIC DISEASES 88
6.2 RESTRAINTS 89
- 6.2.1 STRINGENT REGULATORY FRAMEWORK FOR PRODUCT APPROVAL 89
- 6.2.2 HIGH INSTALLATION AND OPERATIONAL COST OF PRECLINICAL IMAGING SYSTEMS 89
6.3 OPPORTUNITIES 90
- 6.3.1 INCREASING ADOPTION OF IMAGING SYSTEMS FOR PRECLINICAL PURPOSE 90
- 6.3.2 GROWING DEMAND FOR NON-INVASIVE SMALL-ANIMAL IMAGING METHODS 90
6.4 CHALLENGES 91
- 6.4.1 LACK OF SKILLED PROFESSIONALS FOR THE EFFECTIVE UTILIZATION OF PRECLINICAL IMAGING SYSTEMS 91
- 6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES 92

7 GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT 93

7.1 OVERVIEW 94
7.2 SYSTEMS 95
- 7.2.1 OPTICAL IMAGING SYSTEMS 96
  - 7.2.1.1 BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS 97
  - 7.2.1.2 STANDALONE FLUORESCENCE IMAGING SYSTEMS 97
  - 7.2.1.3 OPTICAL + X-RAY/OPTICAL + CT 97
- 7.2.2 PRECLINICAL NUCLEAR IMAGING SYSTEMS 97
  - 7.2.2.1 MICRO-POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS 97
  - 7.2.2.2 MICRO-SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SYSTEMS 97
  - 7.2.2.3 TRIPRODUCT (SPECT/PET/CT) SYSTEMS 98
- 7.2.3 MICRO-MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 98
- 7.2.4 MICRO-COMPUTED TOMOGRAPHY (CT) SYSTEMS 98
- 7.2.5 MICRO-ULTRASOUND SYSTEMS 98
- 7.2.6 PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS 98
- 7.2.7 PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS 98
- 7.2.8 MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI) 98
7.3 SERVICES 99

8 GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS 100

8.1 OVERVIEW 101
8.2 PRECLINICAL OPTICAL IMAGING REAGENTS 102
- 8.2.1 BIOLUMINESCENT IMAGING REAGENTS 103
- 8.2.2 FLUORESCENT IMAGING REAGENTS 103
8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS 103
- 8.3.1 PRECLINICAL PET TRACERS 104
- 8.3.2 PRECLINICAL SPECT PROBES 104
8.4 PRECLINICAL MRI CONTRAST AGENTS 104
- 8.4.1 GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS 105
- 8.4.2 MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS 105
- 8.4.3 IRON-BASED PRECLINICAL MRI CONTRAST AGENTS 105
8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS 105
8.6 PRECLINICAL CT CONTRAST AGENTS 106
- 8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS 106
- 8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS 106
- 8.6.3 GOLD NANOPARTICLES 107
- 8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS 107

9 GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION 108

9.1 OVERVIEW 109
9.2 RESEARCH AND DEVELOPMENT 110
9.3 DRUG DISCOVERY 111
9.4 BIO-DISTRIBUTION 111
9.5 CANCER CELL DETECTION 112
9.6 BIO-MARKERS 112
9.7 OTHERS 113

10 GLOBAL PRECLINICAL IMAGING MARKET, BY END USER 114

10.1 OVERVIEW 115
10.2 CONTRACT RESEARCH ORGANIZATION 116
10.3 PHARMACEUTICAL & BIOTECH COMPANIES 117
10.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES 117
10.5 DIAGNOSTICS CENTER 118
10.6 OTHERS 118

11 GLOBAL PRECLINICAL IMAGING MARKET, BY REGION 119

11.1 OVERVIEW 120
11.2 NORTH AMERICA 123
11.3 EUROPE 158
11.4 ASIA-PACIFIC 257
11.5 SOUTH AMERICA 356
11.6 MIDDLE EAST AND AFRICA 383

12 GLOBAL PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE 437

12.1 COMPANY SHARE ANALYSIS: GLOBAL 437
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 438
12.3 COMPANY SHARE ANALYSIS: EUROPE 439
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 440

13 SWOT ANALYSIS 441

14 COMPANY PROFILE 442

14.1 PERKINELMER INC. 442
- 14.1.1 COMPANY SNAPSHOT 442
- 14.1.2 REVENUE ANALYSIS 442
- 14.1.3 COMPANY SHARE ANALYSIS 443
- 14.1.4 PRODUCT PORTFOLIO 443
- 14.1.5 RECENT DEVELOPMENT 444
14.2 FUJIFILM VISUALSONICS, INC 445
- 14.2.1 COMPANY SNAPSHOT 445
- 14.2.2 REVENUE ANALYSIS 445
- 14.2.3 COMPANY SHARE ANALYSIS 446
- 14.2.4 PRODUCT PORTFOLIO 446
- 14.2.5 RECENT DEVELOPMENT 446
14.3 BRUKER 447
- 14.3.1 COMPANY SNAPSHOT 447
- 14.3.2 REVENUE ANALYSIS 447
- 14.3.3 COMPANY SHARE ANALYSIS 448
- 14.3.4 PRODUCT PORTFOLIO 448
- 14.3.5 RECENT DEVELOPMENT 448
14.4 HOLOGIC, INC. 449
- 14.4.1 COMPANY SNAPSHOT 449
- 14.4.2 REVENUE ANALYSIS 449
- 14.4.3 COMPANY SHARE ANALYSIS 450
- 14.4.4 PRODUCT PORTFOLIO 450
- 14.4.5 RECENT DEVELOPMENT 450
14.5 ZEISS INTERNATIONAL 451
- 14.5.1 COMPANY SNAPSHOT 451
- 14.5.2 REVENUE ANALYSIS 451
- 14.5.3 COMPANY SHARE ANALYSIS 452
- 14.5.4 PRODUCT PORTFOLIO 452
- 14.5.5 RECENT DEVELOPMENTS 452
14.6 ADVANCED MOLECULAR VISION, INC. 453
- 14.6.1 COMPANY SNAPSHOT 453
- 14.6.2 PRODUCT PORTFOLIO 453
- 14.6.3 RECENT DEVELOPMENTS 453
14.7 AGILENT TECHNOLOGIES, INC. 454
- 14.7.1 COMPANY SNAPSHOT 454
- 14.7.2 REVENUE ANALYSIS 454
- 14.7.3 PRODUCT PORTFOLIO 455
- 14.7.4 RECENT DEVELOPMENT 455
14.8 AI4R 456
- 14.8.1 COMPANY SNAPSHOT 456
- 14.8.2 PRODUCT PORTFOLIO 456
- 14.8.3 RECENT DEVELOPMENT 456
14.9 ASPECT IMAGING LTD. 457
- 14.9.1 COMPANY SNAPSHOT 457
- 14.9.2 PRODUCT PORTFOLIO 457
- 14.9.3 RECENT DEVELOPMENT 457
14.10 BERTHOLD TECHNOLOGIES GMBH & CO.KG 458
- 14.10.1 COMPANY SNAPSHOT 458
- 14.10.2 PRODUCT PORTFOLIO 458
- 14.10.3 RECENT DEVELOPMENT 458
14.11 CUBRESA INC. 459
- 14.11.1 COMPANY SNAPSHOT 459
- 14.11.2 PRODUCT PORTFOLIO 459
- 14.11.3 RECENT DEVELOPMENT 459
14.12 HAMAMATSU PHOTONICS K.K. 460
- 14.12.1 COMPANY SNAPSHOT 460
- 14.12.2 REVENUE ANALYSIS 460
- 14.12.3 PRODUCT PORTFOLIO 461
- 14.12.4 RECENT DEVELOPMENT 461
14.13 IVIM TECHNOLOGY CORP. 462
- 14.13.1 COMPANY SNAPSHOT 462
- 14.13.2 PRODUCT PORTFOLIO 462
- 14.13.3 RECENT DEVELOPMENT 462
14.14 KUB TECHNOLOGES INC. 464
- 14.14.1 COMPANY SNAPSHOT 464
- 14.14.2 PRODUCT PORTFOLIO 464
- 14.14.3 RECENT DEVELOPMENT 464
14.15 LI-COR, INC. 465
- 14.15.1 COMPANY SNAPSHOT 465
- 14.15.2 PRODUCT PORTFOLIO 465
- 14.15.3 RECENT DEVELOPMENT 465
14.16 MEDISO LTD. 466
- 14.16.1 COMPANY SNAPSHOT 466
- 14.16.2 PRODUCT PORTFOLIO 466
- 14.16.3 RECENT DEVELOPMENT 466
14.17 MILABS B.V. 467
- 14.17.1 COMPANY SNAPSHOT 467
- 14.17.2 PRODUCT PORTFOLIO 467
- 14.17.3 RECENT DEVELOPMENT 467
14.18 MR SOLUTIONS 468
- 14.18.1 COMPANY SNAPSHOT 468
- 14.18.2 PRODUCT PORTFOLIO 468
- 14.18.3 RECENT DEVELOPMENT 468
14.19 PHOTON ETC 469
- 14.19.1 COMPANY SNAPSHOT 469
- 14.19.2 PRODUCT PORTFOLIO 469
- 14.19.3 RECENT DEVELOPMENT 469
14.20 SOFIE 470
- 14.20.1 COMPANY SNAPSHOT 470
- 14.20.2 PRODUCT PORTFOLIO 470
- 14.20.3 RECENT DEVELOPMENT 470
14.21 TRIFOIL IMAGING 471
- 14.21.1 COMPANY SNAPSHOT 471
- 14.21.2 PRODUCT PORTFOLIO 471
- 14.21.3 RECENT DEVELOPMENT 471
14.22 VIEWORKS CO., LTD. 472
- 14.22.1 COMPANY SNAPSHOT 472
- 14.22.2 REVENUE ANALYSIS 472
- 14.22.3 PRODUCT PORTFOLIO 473
- 14.22.4 RECENT DEVELOPMENT 473

前臨床イメージングの世界市場 - 産業動向と予測（～2030年）

Global Preclinical Imaging Market - Industry Trends and Forecast to 2030

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 規制の枠組み

第6章 市場の概要

第7章 世界の前臨床イメージング市場：製品別

第8章 世界の前臨床イメージング市場：試薬別

第9章 世界の前臨床イメージング市場：用途別

第10章 世界の前臨床イメージング市場：エンドユーザー別

第11章 世界の前臨床イメージング市場：地域別

第12章 世界の前臨床イメージング市場、企業情勢

第13章 SWOT分析

第14章 企業プロファイル

第15章 アンケート

第16章 関連レポート

LIST OF TABLES

LIST OF FIGURES

Market Segmentation

Overview of Global Preclinical Imaging Market Dynamics

Market Players

Some of the key market players in the global preclinical imaging market are:

Market Segmentation

Overview of Global Preclinical Imaging Market Dynamics

Market Players

Some of the key market players in the global preclinical imaging market are:

TABLE OF CONTENTS

1 INTRODUCTION 55

2 MARKET SEGMENTATION 60

3 EXECUTIVE SUMMARY 73

4 PREMIUM INSIGHTS 76

5 REGULATORY FRAMEWORK 82

6 MARKET OVERVIEW 85

7 GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT 93

8 GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS 100

9 GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION 108

10 GLOBAL PRECLINICAL IMAGING MARKET, BY END USER 114

11 GLOBAL PRECLINICAL IMAGING MARKET, BY REGION 119

12 GLOBAL PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE 437

13 SWOT ANALYSIS 441

14 COMPANY PROFILE 442

15 QUESTIONNAIRE 474

16 RELATED REPORTS 477

第1章イントロダクション

第2章市場セグメンテーション

第3章エグゼクティブサマリー

第4章重要考察

第5章規制の枠組み

第6章市場の概要

第7章世界の前臨床イメージング市場：製品別

第8章世界の前臨床イメージング市場：試薬別

第9章世界の前臨床イメージング市場：用途別

第10章世界の前臨床イメージング市場：エンドユーザー別

第11章世界の前臨床イメージング市場：地域別

第12章世界の前臨床イメージング市場、企業情勢

第14章企業プロファイル

第15章アンケート

第16章関連レポート